HAMELN PHARMA GMBH
1Patents
1Active
1Granted
38Portfolio score
Filing activity: Oct 25, 2019 → Oct 25, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10844014B2 | Intermediates for the preparation of remifentanil hydrochloride | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.